Various pathologies, including defective insulin secretion from pancreatic beta cells, inadequate hepatic glucose production, and peripheral insulin resistance, are involved in the development of the disease, and several therapeutic approaches have been attempted to treat this metabolic syndrome 172. This evidence concerns the gene INS and Insulin resistance.